ADNKronos Immediapress

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

(Adnkronos) - Reykjavik, ICELAND, Nov. 6, 2023 /PRNewswire/ -- A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today...

Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations

(Adnkronos) - Standalone business providing energy resilience solutions expected to benefit from Platinum Equity's carve-out experience and operationa...

China Eastern incrementerà i voli internazionali e regionali settimanali a oltre 1.000

(Adnkronos) - SHANGHAI, 6 novembre 2023 /PRNewswire/ - Il settore dell'aviazione cinese ha implementato il nuovo programma di voli per la stagione inv...

Reuters Events announces winners of the 14th Responsible Business Awards 2023 in London

(Adnkronos) - LONDON, Nov. 6, 2023 /PRNewswire/ -- Reuters Events announced the winners of the 14th Responsible Business Awards at the in-person cerem...

Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients

(Adnkronos) - Patients with Lupus share their health experiences within a secure registry to advance research, support better clinical decision-making...

The Saudi-Arab-African Economic Conference Kicks Off Next Thursday

(Adnkronos) - In Participation of Leaders and Decision Makers RIYADH, Saudi Arabia, Nov. 5, 2023 /PRNewswire/ -- The Saudi-Arab-African Economic Co...

JIGOO Unveils P300: An Ultimate Grooming Vacuum for Pets to Enjoy a Salon-Like Experience at Home

(Adnkronos) - LOS ANGELES, Nov. 3, 2023 /PRNewswire/ -- JIGOO, a brand renowned for its achievements in the smart anti-mite field, today presents its...

ELEGOO Unveils the OrangeStorm Giga, A Game-Changing 3D Printing Innovation on Kickstarter

(Adnkronos) - Introducing the Future of Large-Format 3D Printing, Allowing Users to Realize Their Biggest Dreams SHENZHEN, China, Nov. 4, 2023 /PRNew...

L'Agenzia Europea dei Medicinali convalida la domanda di autorizzazione all'immissione in commercio dei Laboratori Pierre Fabre per la combinazione BRAFTOVI® (encorafenib) e MEKTOVI® (binimetinib) per i pazienti affetti da carcinoma polmonare non a piccol

(Adnkronos) - CASTRES, Francia, 3 novembre 2023 /PRNewswire/ -- I Laboratori Pierre Fabre hanno annunciato oggi che l'Agenzia europea per i medicinal...

L'Agenzia Europea dei Medicinali convalida la domanda di autorizzazione all'immissione in commercio dei Laboratori Pierre Fabre per la combinazione BRAFTOVI® (encorafenib) e MEKTOVI® (binimetinib) per i pazienti affetti da carcinoma polmonare non a piccol

(Adnkronos) - CASTRES, Francia, 3 novembre 2023 /PRNewswire/ -- I Laboratori Pierre Fabre hanno annunciato oggi che l'Agenzia europea per i medicinal...